(Bloomberg) -- H. Lundbeck A/S agreed to acquire Longboard Pharmaceuticals Inc in a $2.6 billion deal that boosts its drug ...
The two drugs will account for nearly two-thirds of Lundbeck's revenues in that year, predicted the company's president and CEO Charl ... has agreed to buy Longboard Pharmaceuticals for $2.6 ...
Longboard Pharmaceuticals LBPH announced that it is set to be acquired by Lundbeck A/S for $60 per share in cash, which ...